PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Functional and Molecular Imaging, The National Institute of Neurological Disorders and Stroke Intramural Research Program, Bethesda, MD, 20892, USA.\', \'Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, 20892, USA.\', \'Viral Vector Core, National Institute of Environmental Health Sciences, NIH/DHHS, Research Triangle Park, NC, 27709, USA.\', \'Neurobiology Laboratory, National Institute of Environmental Health Sciences, NIH/DHHS, Research Triangle Park, NC, 27709, USA.\', \'Center for Biomolecular Science and Engineering, US Naval Research Laboratory, Washington, DC, 20375, USA.\', \'Laboratory of Functional and Molecular Imaging, The National Institute of Neurological Disorders and Stroke Intramural Research Program, Bethesda, MD, 20892, USA. david.brody@nih.gov.\', \'Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA. david.brody@nih.gov.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-020-79036-0
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33353972
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all